Free Trial

PowerUp Acquisition (PWUP) Competitors

PowerUp Acquisition logo
$0.52 +0.10 (+25.07%)
As of 07/24/2025

PWUP vs. AIMD, CYCN, PHXM, LIXT, ARTL, LSB, IMNN, SNSE, APRE, and CLRB

Should you be buying PowerUp Acquisition stock or one of its competitors? The main competitors of PowerUp Acquisition include Ainos (AIMD), Cyclerion Therapeutics (CYCN), PHAXIAM Therapeutics (PHXM), Lixte Biotechnology (LIXT), Artelo Biosciences (ARTL), LakeShore Biopharma (LSB), Imunon (IMNN), Sensei Biotherapeutics (SNSE), Aprea Therapeutics (APRE), and Cellectar Biosciences (CLRB). These companies are all part of the "pharmaceutical products" industry.

PowerUp Acquisition vs. Its Competitors

Ainos (NASDAQ:AIMD) and PowerUp Acquisition (NASDAQ:PWUP) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends.

Ainos has a beta of 2.13, meaning that its share price is 113% more volatile than the S&P 500. Comparatively, PowerUp Acquisition has a beta of 0.05, meaning that its share price is 95% less volatile than the S&P 500.

19.2% of PowerUp Acquisition shares are owned by institutional investors. 10.4% of Ainos shares are owned by company insiders. Comparatively, 48.0% of PowerUp Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

PowerUp Acquisition's return on equity of 0.00% beat Ainos' return on equity.

Company Net Margins Return on Equity Return on Assets
AinosN/A -88.07% -48.60%
PowerUp Acquisition N/A N/A N/A

In the previous week, Ainos had 1 more articles in the media than PowerUp Acquisition. MarketBeat recorded 1 mentions for Ainos and 0 mentions for PowerUp Acquisition. Ainos' average media sentiment score of 0.63 beat PowerUp Acquisition's score of 0.00 indicating that Ainos is being referred to more favorably in the media.

Company Overall Sentiment
Ainos Positive
PowerUp Acquisition Neutral

PowerUp Acquisition has lower revenue, but higher earnings than Ainos.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$106.21K101.83-$14.86M-$6.45-0.40
PowerUp AcquisitionN/AN/AN/AN/AN/A

Summary

Ainos and PowerUp Acquisition tied by winning 4 of the 8 factors compared between the two stocks.

Get PowerUp Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for PWUP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PWUP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PWUP vs. The Competition

MetricPowerUp AcquisitionHolding Offices IndustryManufacturing SectorNASDAQ Exchange
Market Cap$4.03M$209.81M$2.18B$9.52B
Dividend YieldN/A3.22%2.57%3.99%
P/E RatioN/A1.8822.1420.02
Price / SalesN/A585.7591.03104.32
Price / CashN/A109.2828.9258.97
Price / BookN/A9.3759.775.90
Net IncomeN/A-$10.64M-$121.56M$258.50M
7 Day Performance45.87%-0.63%0.77%2.12%
1 Month Performance90.71%-0.86%2.49%12.62%
1 Year Performance-95.38%109.54%25.59%19.25%

PowerUp Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PWUP
PowerUp Acquisition
N/A$0.52
+25.1%
N/A-96.3%$4.03MN/A0.00N/AHigh Trading Volume
AIMD
Ainos
1.559 of 5 stars
$2.70
+2.3%
N/A-24.0%$11.07M$20K0.0040
CYCN
Cyclerion Therapeutics
2.5328 of 5 stars
$3.19
-5.3%
N/A-8.5%$10.82M$2M-2.7530Positive News
PHXM
PHAXIAM Therapeutics
N/A$3.10
flat
N/AN/A$10.58MN/A0.0049
LIXT
Lixte Biotechnology
0.2802 of 5 stars
$4.25
+8.4%
N/A+79.7%$10.52MN/A-2.934
ARTL
Artelo Biosciences
3.0517 of 5 stars
$14.17
-2.6%
$25.00
+76.4%
+66.2%$10.25MN/A-0.795Gap Down
LSB
LakeShore Biopharma
0.9009 of 5 stars
$1.18
+9.3%
N/A-72.7%$10.05M$80.82M0.00773Positive News
Gap Down
IMNN
Imunon
1.9526 of 5 stars
$0.62
+11.4%
$15.50
+2,385.6%
-58.4%$9.82M$500K0.0030Stock Split
SNSE
Sensei Biotherapeutics
4.6504 of 5 stars
$7.21
-6.5%
$90.00
+1,148.3%
-47.8%$9.72MN/A-0.3140Positive News
APRE
Aprea Therapeutics
2.9241 of 5 stars
$2.08
+20.2%
$15.50
+645.2%
-50.1%$9.57M$1.50M-0.887Positive News
High Trading Volume
CLRB
Cellectar Biosciences
2.5399 of 5 stars
$5.20
-0.6%
$375.00
+7,111.5%
-92.4%$9.47MN/A-0.2410Positive News

Related Companies and Tools


This page (NASDAQ:PWUP) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners